One reagent for two techniques: Compound [ 111In]1 provides a platform for sequential radionuclide and optical imaging of prostate cancer through targeting of the prostate-specific membrane antigen. Because the same subject can be dual-imaged after one injection of the agent, these findings support rapid clinical translation.
- fluorescent probes
- imaging agents
- prostate cancer
- prostate-specific membrane antigen
ASJC Scopus subject areas